Dutch DSM commences tender to buy US’ Kensey Nash

21 May 2012 08:23  [Source: ICIS news]

SINGAPORE (ICIS)--DSM has commenced its previously announced cash tender offer for all outstanding shares of US-based biomedical firm Kensey Nash at $38.50 (€30) per share, or about $360m, the Dutch specialty chemicals firm said on Monday.

The tender offer is scheduled to expire on 18 June this year, unless the offer is extended, the company said in a statement.

Kensey Nash is mainly focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology, it said.

($1 = €0.78)


By: Nurluqman Suratman



AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly